UOC

UBS O'Connor Portfolio holdings

AUM $3.76B Turnover 54.76%
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.22B
AUM Growth
-$1.2B
Cap. Flow
-$1.32B
Cap. Flow %
-31.23%
Top 10 Hldgs %
40.53%
Holding
893
New
143
Increased
129
Reduced
82
Closed
273
Avg Time Held Equity + Options
0.9 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
0.9 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.2 years

Top Buys

Rank Stock Value
1
OSH
Oak Street Health, Inc.
OSH
+$211M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$189M
3
UNVR
Univar Solutions Inc.
UNVR
+$175M
4
MAXR
Maxar Technologies Inc. Common Stock
MAXR
+$143M
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$137M

Top Sells

Rank Stock Value
1
STOR
STORE Capital Corporation
STOR
+$414M
2
LHCG
LHC Group LLC
LHCG
+$211M
3
ATVI
Activision Blizzard
ATVI
+$196M
4
SGFY
Signify Health, Inc.
SGFY
+$161M
5
ONEM
1Life Healthcare
ONEM
+$141M

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.3%
3 Technology 18.64%
4 Miscellaneous 15.12%
5 Industrials 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CRL icon
426
Charles River Laboratories
CRL
$14.5B
$616K 0.01%
3,053
-3,121
-51% -$707K
2022 Q4
1 quarter
H icon
427
PUT
Hyatt Hotels
H
$15.1B
$600K 0.01%
215,500
+198,000
+1,131% +$21.7M
2022 Q1
4 quarters
INBX icon
428
DELISTED
Inhibrx, Inc. Common Stock
INBX
$600K 0.01%
31,800
-57,000
-64% -$1.33M
2022 Q2
3 quarters
EDR icon
429
DELISTED
Endeavor Group Holdings, Inc.
EDR
$598K 0.01%
+25,000
New +$557K
2023 Q1
0 quarters
RAIN icon
430
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$593K 0.01%
67,842
-233,114
-77% -$2.16M
2022 Q1
4 quarters
SLN icon
431
Silence Therapeutics
SLN
$555M
$591K 0.01%
95,383
+6,447
+7% +$76K
2022 Q2
3 quarters
SPY icon
432
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$586K 0.01%
395,000
-285,000
-42% -$114M
2019 Q4
13 quarters
ESTC icon
433
Elastic
ESTC
$9.7B
$579K 0.01%
+10,000
New +$570K
2023 Q1
0 quarters
CNTB icon
434
Connect Biopharma Holdings
CNTB
$56.7M
$574K 0.01%
574,148
+6,559
+1% +$7.15K
2022 Q2
3 quarters
DBTX
435
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$572K 0.01%
189,386
+1,420
+0.8% +$4.91K
2022 Q2
3 quarters
PTON icon
436
PUT
Peloton Interactive
PTON
$2.2B
$567K 0.01%
+485,000
New +$5.83M
2023 Q1
0 quarters
PROK icon
437
ProKidney
PROK
$305M
$564K 0.01%
+49,782
New +$530K
2023 Q1
0 quarters
RIG icon
438
PUT
Transocean
RIG
$6.29B
$558K 0.01%
485,000
-1,482,700
-75% -$9.52M
2018 Q2
19 quarters
CRNX icon
439
DELISTED
Crinetics Pharmaceuticals
CRNX
$537K 0.01%
33,421
-79,000
-70% -$1.46M
2022 Q1
4 quarters
RIVN icon
440
Rivian
RIVN
$18.6B
$526K 0.01%
+34,000
New +$574K
2023 Q1
0 quarters
GPCR icon
441
Structure Therapeutics
GPCR
$1.59B
$525K 0.01%
+22,050
New +$518K
2023 Q1
0 quarters
LCA
442
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
$521K 0.01%
51,785
– –
2021 Q2
7 quarters
RIOT icon
443
Riot Platforms
RIOT
$5.58B
$519K 0.01%
+52,000
New +$338K
2023 Q1
0 quarters
PTC icon
444
PTC
PTC
$21B
$513K 0.01%
4,000
-11,000
-73% -$1.4M
2022 Q4
1 quarter
CCL icon
445
Carnival Corporation Ltd
CCL
$34.7B
$500K 0.01%
49,250
-12,600
-20% -$131K
2022 Q4
1 quarter
TRIP icon
446
TripAdvisor
TRIP
$1.03B
$497K 0.01%
+25,000
New +$534K
2023 Q1
0 quarters
RETA
447
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$477K 0.01%
+5,250
New +$308K
2023 Q1
0 quarters
SDGR icon
448
Schrodinger
SDGR
$1.88B
$476K 0.01%
18,081
-67,000
-79% -$1.59M
2022 Q1
4 quarters
EDIT icon
449
Editas Medicine
EDIT
$352M
$464K 0.01%
+64,050
New +$569K
2023 Q1
0 quarters
INTU icon
450
Intuit
INTU
$81.9B
$446K 0.01%
+1,000
New +$411K
2023 Q1
0 quarters
16 17
18
19 20

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 893 positions worth $4.22B, down 22% from $5.42B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $1.32B in Q1 2023, closing 273 positions and reducing 82 holdings. Its most notable exit was STORE Capital Corporation, an estimated $414M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.

Against the trend, UBS O'Connor opened a new position in Oak Street Health, Inc. worth $25.3M.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited STORE Capital Corporation in Q1 2023, selling an estimated $414M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 143 new positions and closed 273 in Q1 2023.
  • UBS O'Connor's portfolio value fell 22% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.